SCHEMBL17876114

SCHEMBL17876114

N#Cc1ccc2c(c1)c1ccccc1n2-c1ccc2c(c1)-c1cc(-c3cc(-c4ccncc4)cc(-c4ccncc4)c3)ccc1OCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 2/20 0.39
EDNRB P24530 1/20 0.39
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
FLT3 P36888 2/20 0.37
TDP2 O95551 1/20 0.36
USP2 O75604 1/20 0.36
GPR142 Q7Z601 1/20 0.35
ALDH1A1 P00352 2/20 0.34
DYRK1A Q13627 1/20 0.34
CYP19A1 P11511 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
MAPK13 O15264 1/20 0.32
TGFBR1 P36897 1/20 0.32
MAPK12 P53778 1/20 0.32
MAPK11 Q15759 1/20 0.32
MAPK14 Q16539 1/20 0.32
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17877604 0.92 EDNRA (0.44) EDNRAEDNRBTDP2USP2ALDH1A1
SCHEMBL17877602 0.90 CYP11B2 (0.42) EDNRAEDNRBFLT3TDP2USP2
SCHEMBL17876115 0.89 EDNRA (0.44) EDNRAEDNRBROCK2ALDH1A1DYRK1A
SCHEMBL17877813 0.88 EDNRA (0.44) EDNRAEDNRBROCK2ROCK1TDP2
SCHEMBL17876217 0.87 FLT3 (0.36) ROCK2ROCK1FLT3GPR142CYP19A1
SCHEMBL17877812 0.87 EDNRA (0.43) EDNRAEDNRBTDP2USP2ALDH1A1
SCHEMBL17877822 0.87 EDNRA (0.43) EDNRAEDNRBTDP2USP2ALDH1A1
SCHEMBL17877887 0.87 EDNRA (0.43) EDNRAEDNRBTDP2USP2ALDH1A1
SCHEMBL17877891 0.87 EDNRA (0.43) EDNRAEDNRBTDP2USP2ALDH1A1
SCHEMBL17877603 0.86 ALDH1A1 (0.42) EDNRAEDNRBFLT3TDP2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 EDNRA 3570/4885EDNRB 4191/4885ROCK2 4451/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 EDNRA 3570/4885EDNRB 4191/4885ROCK2 4451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.